The course of treatment
The doctor in charge.
From 4 weeks.
Any spot on the earth, almost any amount of the medicine.
A guarantee of quality
The maximum percentage recovery and the relapse percentage is close to zero.
High qualified specialists
At any time you can be advised on all issues
Welcome toKAMAL pharmaceuticals site
Not each of us is faced with a serious problem such as Hepatitis C. But if the disease is diagnosed, what should we do? Unfortunately, ordinary government hospitals are not always able to go further than the diagnosis of the problem and, as a result, an untrained person is left alone with his problem.
Low awareness, weak support from the health services — all these pitfalls in our lives, it does not contribute to the cure of the dreaded disease. Fortunately, the manifestation of proper attention to detail you can easily and simply make out a kind of ray of hope, and our site can help you.
KPH company – is a manufacturer of drugs against hepatitis C. We have a full range of drugs for the treatment and prevention of relapse. We work with the largest dealers in different countries of the world and achieve incredible results. Our production is based in India, which is a leader country in the production of medicines and effective components for them. The experts of the scientific laboratories of the brand have managed to develop such tools, which reduce the chance of recurrence to zero. Sofosbuvir, Daclatasvir, Ledipasvir - this is much more than the names of regular medicines. According to the right approach to treatment and admission plan you will forget that something separates you from ordinary people.
During the work our company has received many commendations of our customers. After the consultation with the doctor-hepatologist, they came to us and overcame their disease once and for all. We are not in a hurry to shift all the credit solely to our preparations. It is obvious that crucial in bright victory over the disease was decision of our customers to change something in their life, in spite of all the difficulties that the disease has in store for them. We, in turn, simply skill support, doing the work for which this company was created.
Please call our contact centre and we will be glad to answer any of your questions. Also applications are accepted via e-mail, specified in the relevant section of the site.
Please contact us by phone or email - we will be happy to answer any of your questions.
Latest news of Kamal Pharmaciuticals
Our company produces drugs for the treatment of Hepatitis C with different genotypes
Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 3 infection. Daclatasvir prevents RNA replication and virion assembly by binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly. Daclatasvir is used together with Sofosbuvir to treat chronic hepatitis C infection. Daclatasvir is available only with your doctor's prescription.Apr 22, 2016 Read more
Sofosbuvir is an antiviral medication that prevents hepatitis C virus (HCV) cells from multiplying in your body. Sofosbuvir is used in combination with other medications to treat hepatitis C in adults. Sofosbuvir is sometimes used in people who also have HIV, or people who have liver cancer and are going to have a liver transplant. Sofosbuvir is not a treatment for HIV or AIDS. Sofosbuvir must be given in combination with other antiviral medications and should not be used alone. Sofosbuvir is usually given with ribavirin (Copegus, Rebetol, Ribasphere, RibaTab) with or without peginterferon alfa (Pegasys, PegIntron).Apr 09, 2016 Read more
Ledipasvir, previously known as GS-5885, is an inhibitor of the Hepatitis C Virus (HCV) NS5A protein required for viral RNA replication and assembly of HCV virions. Although its exact mechanism of action is unknown, it is postulated to prevent hyperphosphorylation of NS5A which is required for viral production. It is effective against genotypes 1a, 1b, 4a, and 5a and with a lesser activity against genotypes 2a and 3a of HCV. Ledipasvir is available as a fixed dose drug combination product with sofosbuvir (tradename Harvoni) used for the treatment of chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). Approved in October 2014 by the FDA, ledipasvir and sofosbuvir are direct-acting antiviral agents indicated for the treatment of HCV genotype 1 with or without cirrhosis. HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States affecting 72% of all chronic HCV patients. Prior to development of this drug, the main treatment available was weekly injections of pegylated interferon with weight-based ribavirin over 48 weeks, which achieved a sustained virological response (SVR) of 45-50% and had multiple unpleasant side effects. When combined together, ledipasvir and sofosbuvir have been shown to have a SVR between 93 and 100% after 12 weeks of treatment. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV.Mar 28, 2016 Read more
What our customers say about us
I write a review of Murmansk and my younger brother. It is after recovery, so began to enjoy life, as they say, the hands do not reach chirkanut. After the Army, he was diagnosed with hepatitis C, genotype 1. After reviewing the entire Internet came to buy drugs and sofosbuvir daklatasvir from an Indian company KPH. About the experience of delivery and what will come dummy could fill a book, but not about that right now. Sending came for 5 days in Moscow, we were in shock! After 4 weeks of taking already received negative. After the 12 weeks passed the tests ... and lo and behold: this infection in the blood brother is not at all !! Thank KPH great company consultants for all their numerous tips and advice for what to periodically called and asked how we all pass, this is even reassuring. All good!
We work with Kamal more than a year, no negative emotions work did not cause, all customers in Kyiv and other cities were satisfied. Some friends advised.
In our country, a very serious competition in the market the treatment of hepatitis C. With all things being equal - Kamal vyygryvaet the quality and speed of delivery. There are representatives in many cities. Learn you how to become a dealer of a serious Indian producer.